7139.T

The company maintains a market price of ¥4,700 per share, with a market capitalization of ¥1.93 billion, and a price-to-earnings ratio of 9.18, which is relatively low compared to the industry median. The price-to-book ratio of 0.6 indicates that the company is trading at a discount to its book value, suggesting potential undervaluation. The company's liquidity position is characterized by a current ratio of 1.17, indicating a moderate ability to meet short-term obligations, while its cash and equivalents of ¥1.11 billion provide some buffer against immediate liquidity pressures.

Profitability metrics show a return on equity of 6.58% and a return on assets of 2.03%, both of which are below the industry median for Commodity Chemicals. The company's operating income of ¥297.8 million and net income of ¥210.4 million reflect a narrow margin structure, with a gross profit of ¥2.92 billion. These figures suggest that the company is operating in a highly competitive environment with limited pricing power.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's revenue of ¥12.27 billion is derived from a single primary business activity, which may limit its ability to adapt to market shifts.

Looking ahead, the company is projected to experience a modest growth trajectory, with revenue expected to increase by a low single-digit percentage in the current fiscal year. The company's capital expenditure of ¥164.15 million indicates a cautious approach to investment, which may limit long-term growth potential. The company's free cash flow of ¥226.2 million provides some flexibility for reinvestment or shareholder returns.

The company faces a medium liquidity risk, as indicated by the risk assessment, with a key flag noting that net cash is negative after subtracting total debt. The debt-to-equity ratio of 0.81 suggests a moderate level of leverage, and the company's dilution risk is assessed as low, with no significant dilution potential in the near term. The company's long-term debt of ¥2.58 billion represents a significant portion of its liabilities, which could impact its financial flexibility.

Recent filings and transcripts indicate that the company has not disclosed any major strategic initiatives or significant operational changes. The company's financial performance has been stable, with no material events reported that would suggest a shift in business strategy or operational focus. The company's risk factors include exposure to commodity price volatility and regulatory changes in the chemical industry.